Elsevier

Molecular Imaging & Biology

Volume 4, Issue 6, November–December 2002, Pages 410-414
Molecular Imaging & Biology

Article
Contamination Levels in Blood Samples Drawn from the Injection Intravenous Line

https://doi.org/10.1016/S1536-1632(02)00121-XGet rights and content

Abstract

Purpose: Securing two intravenous lines, one for injection and one for blood sampling, can be nearly impossible in compromised patients, therefore, a need exists to quantify the potential error when simplified techniques are employed.

Method: Two venous catheters were placed. 2-deoxy-2-[18F]fluoro-glucose (FDG) was infused through one of the catheters. Venous blood samples were drawn from each line. Triplicate aliquots of plasma were analyzed in duplicate.

Results: Concentrations from the infusion line were 2.0% higher than the concentrations from the noninfusion line. The average error was 3.3%, 2.0%, and 0.7% higher for the first, second, and third samples, respectively.

Conclusions: Blood sampling through the infusion catheter is a viable alternative to the placement of separate venous catheters. Sampling from the injection catheter, even with tubing flush and replacement, will potentially incur small (generally < 10%) overestimations in concentration in initial samples. Subsequent sampling reduces the error to essentially zero by the third sample.

Introduction

Positron emission tomography (PET) with 2-deoxy-2-[18F]fluoro-glucose (FDG) is used for the diagnosis, staging, and treatment monitoring of heart, brain, and oncologic disease. Functional tissue information is available from both the images produced, as well as the pharmacokinetic behavior of the tracer. In PET imaging, through the implementation of tracer kinetic models, a number of physiological parameters may be calculated such as tissue blood flow, receptor density or in the case of the use of FDG, glucose metabolic rate. Frequently, the implementation of these models requires some type of blood sampling for the determination of arterial input functions, even when population-based curves are employed. Patients undergoing these studies are frequently compromised to such an extent that securing two separate intravenous lines, one for drug injection and one for venous blood sampling, can be extremely difficult if not impossible. Yet, just as with therapeutic drug monitoring, it is frequently these very same patients that the need for the information derived from blood sampling may be the most urgent. Therefore, a need exists to develop standard techniques for the minimization of contamination and for estimates of the degree of contamination when a single intravenous catheter is utilized, and to quantify the potential sampling error when simplified sampling and assay techniques are employed.

It was the purpose of the present investigation to examine the potential errors associated with simplified blood sampling techniques amenable to clinical situations.

Section snippets

Materials and Methods

All subjects provided written informed consent in compliance with guidelines of the University of Iowa Institutional Review Board and Radiation Protection Committee and were participants in an imaging study to monitor the effects of neoadjuvant therapy in the treatment of thoracic esophageal carcinoma. Two venous catheters (20 gauge) were placed, one in each antecubital vein. A saline flushed t-port was attached to each line. FDG, 370–555 MBq (10–15 mCi adjusted to body weight), was infused

Results

Data were available for 20 patients (30 sets of measurements; Table 1). In a paired analysis, the concentrations determined from the samples drawn from the infusion line were 2.0% higher than the concentrations determined from the samples drawn from the noninfusion line. This difference was statistically significant (t89 = −3.05, P = 0.003). In 27 of 31 initial draws, the IL sample was higher (n = 21) or analytically equivalent (n = 6) (see discussion below) to the NL sample. In two cases, the

Discussion

Real-world clinical scenarios require that the rigors generally employed in research protocols be streamlined in order to accommodate the patient's medical condition, as well as the staffing levels of busy imaging centers. Clinical PET imaging is faced with the need to provide the imaging information that has been developed in research protocols (e.g., metabolic rates) without unduly compromising patient comfort or overly challenging limited staff resources. The need and extent of blood

Conclusions

Blood sampling through the infusion catheter is a viable alternative to the placement of separate venous catheters. Sampling from the injection catheter, even with tubing flush and replacement, will potentially incur small overestimations in concentration levels in initial samples (i.e., approximately 85% of samples <5% errors). Subsequent sampling reduces the error to essentially zero by the third sample. Depending on the sensitivity of the parameter estimation procedures to tracer

Acknowledgements

The project described was supported by Grant Number 7 R01 CA74959-04 from NIH, Dr. Michael M. Graham, M.D., Ph.D., principal investigator. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.

References (2)

  • Hichwa, R.D.; Ponto, L.L.B.; Watkins, G.L. Clinical blood flow measurements with [15O]water and positron emission...
  • C.J. Hoekstra et al.

    On the use of the injection catheter for venous blood sampling in quantitative FDG PET studies

    Eur. J. Nucl. Med.

    (2000)

Cited by (7)

View all citing articles on Scopus
View full text